Publicacións nas que colabora con Marisa Crespo Leiro (35)

2024

  1. Prognostic impact of chronic obstructive pulmonary disease and bronchial asthma in patients with heart failure

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 123-132

  2. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Clinical outcomes in heart transplant recipients with coronary abnormalities in the donor graft

    Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 473-474

  2. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

  3. Survival impact of previous statin therapy in patients hospitalized with COVID-19

    Medicina Clinica, Vol. 160, Núm. 1, pp. 1-9

2022

  1. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact

    European Journal of Internal Medicine, Vol. 105, pp. 89-96

  2. Clinical profile and causes of death according to ejection fraction in patients with heart failure cared for in a specialized Cardiology unit

    Revista Clinica Espanola, Vol. 222, Núm. 3, pp. 152-160

  3. Furosemida subcutánea mediante infusor elastomérico en pacientes ambulatorios con insuficiencia cardiaca. Experiencia inicial

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 86, pp. 45-49

  4. Prognostic value of a model based on IC-BERG recommendations in ambulatory patients with heart failure

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 76-84

  5. Real world comparison of spironolactone and eplerenone in patients with heart failure

    European Journal of Internal Medicine, Vol. 97, pp. 86-94

2021

  1. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

  2. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378

2020

  1. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

  2. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 652-659

  3. Diagnostic and prognostic value of cardiac imaging in amyloidosis

    World Journal of Cardiology, Vol. 12, Núm. 12, pp. 599-614

  4. In-Hospital Post-Operative Infection after Heart Transplantation: Epidemiology, Clinical Management, and Outcome

    Surgical Infections, Vol. 21, Núm. 2, pp. 179-191

  5. Incidence, risk factors and prognostic impact of cytomegalovirus infection after heart transplantation

    Medicina Clinica, Vol. 154, Núm. 10, pp. 381-387

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

  2. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 899-906

  3. In-hospital postoperative infection after heart transplantation: Risk factors and development of a novel predictive score

    Transplant Infectious Disease, Vol. 21, Núm. 4